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Fungiform Papilla Pattern: EGF Regulates
Inter-Papilla Lingual Epithelium and
Decreases Papilla Number by Means of PI3K/
Akt, MEK/ERK, and p38 MAPK Signaling
Hong-Xiang Liu,1 Bradley S. Henson,2† Yanqiu Zhou,1 Nisha J. D’Silva,3 and Charlotte M. Mistretta1*
Fungiform papillae are epithelial taste organs that form on the tongue, requiring differentiation of papillae
and inter-papilla epithelium. We tested roles of epidermal growth factor (EGF) and the receptor EGFR in
papilla development. Developmentally, EGF was localized within and between papillae whereas EGFR was
progressively restricted to inter-papilla epithelium. In tongue cultures, EGF decreased papillae and
increased cell proliferation in inter-papilla epithelium in a concentration-dependent manner, whereas
EGFR inhibitor increased and fused papillae. EGF preincubation could over-ride disruption of Shh
signaling that ordinarily would effect a doubling of fungiform papillae. With EGF-induced activation of
EGFR, we demonstrated phosphorylation in PI3K/Akt, MEK/ERK, and p38 MAPK pathways; with pathway
inhibitors (LY294002, U0126, SB203580) the EGF-mediated decrease in papillae was reversed, and
synergistic actions were shown. Thus, EGF/EGFR signaling by means of PI3K/Akt, MEK/ERK, and p38 MAPK
contributes to epithelial cell proliferation between papillae; this biases against papilla differentiation and
reduces numbers of papillae. Developmental Dynamics 237:2378–2393, 2008. © 2008 Wiley-Liss, Inc.
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INTRODUCTION
Taste papilla development and pat-
terning require interactive programs
both for induction of the specific organ
and differentiation of inter-papilla ep-
ithelium (Mistretta and Liu, 2006).
Whereas the development of fungi-
form papillae in their distinctive pat-
tern has long been noted (Mistretta,
1972, 1998; Mbiene et al., 1997), there
is not a clear understanding of molec-
ular events in papilla patterning. EGF
is a potent secreted factor that has
reported roles in spacing other epithe-
lial specializations including hair
(Mak and Chan, 2003), feather (Atit et
al., 2003), and denticle (Urban et al.,
2004), but potential regulatory roles
for EGF in fungiform papilla pattern-
ing have not been studied. Therefore,
distinctions or developmental general-
izations between EGF actions in skin
vs. lingual specialized organs are not
known. Here, we demonstrate roles of
EGF and EGFR in defining the inter-
papilla space in embryonic rat tongue;
report EGF effects in lingual epithe-
lial cell proliferation; and, identify in-
tracellular signaling pathways that
mediate EGF effects.
The mammalian tongue hosts three
types of taste papillae: fungiform, cir-
cumvallate, and foliate, each with a
unique location, morphology, and in-
nervation to resident taste buds. Fun-
giform papillae develop in diagonal
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rows on the anterior two-thirds of the
rodent tongue, from a homogeneous
epithelium that covers the three lin-
gual swellings at embryonic day (E) 13
in rat (Mistretta, 1972, 1991; Mbiene
et al., 1997) or E11.5–E12 in mouse
(Kaufman, 1992). Approximately 1
day later, E14, when lingual swellings
have merged into a spatulate tongue,
papilla placodes are first identified as
focal cell clusters. By E15, the tongue
has a distinctive topography and fungi-
form papillae are in rows on anterior
tongue (Mistretta, 1972; Mbiene et al.,
1997). The nontaste, heavily keratin-
ized filiform papillae that cover inter-
papilla epithelium in the postnatal
tongue are not visible until approxi-
mately E20. Furthermore, histologically
defined, early taste buds are not seen in
rodent papillae until just before birth;
taste bud development is essentially post-
natal (Mistretta, 1991; Hill, 2001).
Functional roles are known for
Sonic hedgehog (SHH; Hall et al.,
2003; Mistretta et al., 2003; Liu et al.,
2004); bone morphogenetic protein
(BMP) 2, 4, and 7 and NOGGIN (Zhou
et al., 2006); SOX2 (Okubo et al.,
2006); and WNT10b (Iwatsuki et al.,
2007; Liu et al., 2007) in regulating
the number and distribution of fungi-
form papillae. These factors have
stage-specific effects and can induce or
inhibit papilla development. However,
in these studies there has not been
attention to the inter-papilla epithe-
lium and in fact, little is known about
regulation of inter-papilla epithelial
differentiation in patterning. There
are specific innervation patterns to
taste papillae compared with inter-pa-
pilla, nontaste epithelium (Mistretta,
1998; Hill, 2001). Therefore, to under-
stand development of sensory func-
tions, it is important to know how dif-
ferentiation programs arise for
gustatory organs vs. filiform papilla
domains. EGF has prominent roles in
cell survival, proliferation, and differ-
entiation (Woodburn, 1999; Harris et
al., 2003; Shilo, 2005), and, therefore,
could have dual functions in papilla and
inter-papilla epithelial development.
Aberrant morphology in surviving,
EGFR null mutant mice previously
suggested a role for EGF in fungiform
papilla development (Miettinen et al.,
1995; Threadgill et al., 1995; Sun and
Oakley, 2002). However, the mice had
compromised face and tongue integ-
rity that limited conclusions about
EGF effects on papillae. In organ cul-
ture, there is a unique opportunity for
direct study of tongue and taste pa-
pilla development in a quantitative
manner, without confounding effects
from oral-facial deformities. The en-
tire tongue progresses from three lin-
gual swellings (at E13) to a spatulate
(E14) and larger (E15–E16) tongue,
and taste papillae form with retention
of spatial, temporal, and molecular in-
formation that is similar to in vivo
development (Mbiene et al., 1997;
Nosrat et al., 2001; Liu et al., 2004).
This culture system now is widely
used to understand papilla develop-
ment (Hall et al., 2003; Mistretta et
al., 2003; Okubo et al., 2006; Zhou et
al., 2006; Iwatsuki et al., 2007).
In the present study, we first iden-
tify specific EGF and EGFR locations
during tongue and papilla develop-
ment. Then, we investigate EGF ef-
fects in tongue cultures begun at two
early embryonic stages, when tongue
epithelium is homogenous and not dif-
ferentiated to papilla or inter-papilla
fates (E13) and just after prepapilla
placodes have begun to emerge (E14).
We show that exogenous EGF regu-
lates patterning by reducing papilla
number, and that EGF action on fun-
giform papillae is mediated by means
of EGFR. Furthermore, we demon-
strate that EGF/EGFR action in-
creases inter-papilla cell proliferation
and can over-ride SHH signaling dis-
ruption that doubles the number of
fungiform papillae. Mediating the ep-
ithelial effects, EGFR-induced intra-
cellular signaling cascades including
phosphatidylinositol 3-kinase (PI3K)/
Akt, MEK/ERK, and p38 MAPK cas-
cades are shown to have specific roles.
Together, results show new roles for
EGF signaling by means of EGFR, in
regulating fungiform papillae and
tongue epithelium development. For
the first time, specific intracellular
cascades are identified in mediating
papilla development.
RESULTS
EGF and EGFR Distribute
Differently in Embryonic
Tongue and Papillae
To determine spatial and temporal
distributions, EGF and EGFR pro-
teins were localized in E13–E18
tongues (Fig. 1, E18 not illustrated).
EGF is not detected in E13, but is
apparent in E14 tongue epithelium
(Fig. 1, EGF-ir, arrowhead points to
papilla placode at E14). At E15, EGF
is in all epithelial layers in both early
papilla and inter-papilla regions (Fig.
1, EGF-ir; arrow identifies fungiform
papilla). Some immunostained cells
are in the mesenchyme also. EGF-ir is
more intense in tongue epithelium
and papillae from E16 to E18 (Fig. 1,
arrow points to fungiform papilla at
E16).
In contrast to EGF, at E13 there
already is EGFR expression in a
patchy distribution in sectioned lin-
gual epithelium, and this is more in-
tense at E14 (Fig. 1, EGFR-ir; arrow-
head identifies E14 papilla placode).
At E13–E14, EGFR is localized
through all layers of the epithelium.
Importantly, from E15 to E18,
EGFR becomes progressively more in-
tense in the inter-papilla space, and
very weak, or not present within fun-
giform papilla epithelium (Fig. 1,
EGFR-ir, arrows point to papillae;
E18 not illustrated). No obvious im-
munoproducts are in the mesenchyme
just beneath the epithelium.
Immunohistochemistry on E13
whole tongue echoes and clarifies the
patchy distribution of EGFR-ir seen in
tongue sections (Fig. 1, EGFR-ir,
Whole tongue, E13). At E14, the
EGFR-ir is dense along the median
furrow (open arrowheads) where a
row of fungiform papillae will form.
Thus, in whole tongue immunoreac-
tions, evidence for an emerging local-
ization of EGFR in relation to papilla
placode zones is apparent. In E15–
E16 whole tongues, EGFR is absent in
developing and well formed papillae,
confirming the result in tongue sec-
tions. Each papilla is delineated as a
blank circle surrounded by a ring of
EGFR immunoproduct (arrows at E15
and E16; inset at E16).
Thus, EGF and EGFR are in dis-
tinctive locations at specific stages
during papilla development. The pro-
gressive, intense distribution of EGFR
in the inter-papilla region vs. absent
or very weak expression within the
fungiform papillae suggests roles for
EGF in regulating epithelial cell fate
between papillae.
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EGF Suppresses Fungiform
Papilla Formation in E13
and E14 Tongue Cultures
To test functional roles for EGF in
papilla development, we used tongue
cultures begun from E13 when the
tongue epithelium has a homogenous
surface topography that has not begun
to differentiate to papilla or inter-pa-
pilla fates, and from E14 when prepa-
pilla placodes have just begun to
emerge on the tongue (Fig. 2, E13 and
E14, 0 day). After 2 days in culture,
fungiform papillae form on anterior
tongue of E13 or E14 cultures (Fig. 2,
E13 and E14, 2 days), in numbers
and location comparable to the embry-
onic tongue at E15 or E16 (Mbiene et
al., 1997). The intermolar eminence
develops and is papilla-free (Fig. 2, 2
days, IE).
Potential EGF effects in develop-
ment of fungiform papillae were
studied in cultures that were main-
tained in the control, standard me-
dium (STAND with 0 ng/ml EGF), or
with increasing concentrations of ex-
ogenous EGF, and examined with
scanning microscopy and whole
tongue immunoreactions for SHH
(Fig. 3).
E13 effects.
In E132 day cultures, the three lin-
gual swellings of the E13 tongue have
grown and merged in STAND or 0
ng/ml EGF (Fig. 3A, E13  2 days, 0
ng/ml EGF, scanning electron micros-
copy [SEM]). Numerous fungiform pa-
pillae are apparent on anterior
tongue. With addition of EGF, there is
a concentration-dependent decrease
in fungiform papilla number in E132
day cultures (Fig. 3A, SEMs, EGF at
1–100 ng/ml). SHH immunoloci,
which mark fungiform papillae (Mis-
tretta et al., 2003), highlight this de-
Fig. 1. Epidermal growth factor (EGF) and its receptor EGFR are in distinctive lingual distributions during fungiform papilla development. EGF and
EGFR immunohistochemistry in sagittal sections and EGFR in whole tongues, embryonic day (E) 13–E16. Arrowheads point to prepapilla placodes,
arrows to fungiform papillae. EGF-ir, EGF immunoreactions: EGF-ir is not apparent at E13 but is first seen in anterior tongue epithelium at E14, and
becomes more intense through E16. EGF is in all layers of papilla and inter-papilla epithelium. EGFR-ir, EGFR immunoreactions: In contrast to EGF,
EGFR-ir appears throughout early epithelium (E13) and has an irregular, patchy distribution in epithelium at prepapilla placode stages (E14). From E15
to E16, EGFR-ir is intense in inter-papilla epithelium, but becomes progressively weak within papillae (arrows). EGFR-ir, in Whole tongue: The anterior
quarter of the tongue is illustrated. Whole tongue immunoreactions reinforce the patchy distribution of EGFR at E13–E14. At E13, EGFR-ir is intense
in small patches of the anterior lingual swelling (L). At E14, in the region of prepapila placodes along the median furrow, there is intense EGFR-ir (open
arrowheads). The absence of EGFR within clearly outlined fungiform papillae from E15 to E16 (arrows) is obvious. Expanded image of E16 papillae in
the inset emphasizes the EGFR-free papilla apex surrounded by the receptor. Scale bars  25 m for all tongue sections, 250 m for whole tongue.
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crease and demonstrate that remain-
ing papillae retain SHH (Fig. 3A, Shh-
ir, right column). Papillae are
decreased by approximately 40% in 10
ng/ml EGF cultures compared with
tongues in 0 ng/ml EGF (Fig. 3B, anal-
ysis of variance [ANOVA] F(4, 37) 
25.7; P  0.01). Very few papillae re-
main, on the tongue tip only, with 100
ng/ml EGF.
E14 effects.
At E14, papilla placodes are small sur-
face eminences (Fig. 2). Over 2 days in
STAND culture with 0 ng/ml EGF,
fungiform papillae develop (Fig. 3C,
E14  2 days, 0 ng/ml, SEM) and SHH
is retained in each papilla (Fig. 3C,
Shh-ir). With EGF, papilla number
decreases in a concentration-depen-
dent manner (Fig. 3C). From 3 ng/ml,
there is a significant decrease in pa-
pillae and at 10 ng/ml EGF there are
approximately 50% of papilla num-
bers observed with 0 ng/ml (Fig. 3D,
ANOVA F(5,46)  42.7; P  0.01).
SHH expression in individual papillae
highlights the reduction (Fig. 3C,
Shh-ir).
Thus, exogenous EGF inhibits for-
mation of fungiform papillae in em-
bryonic tongue cultures, in a concen-
tration-dependent manner, whether
EGF is introduced before (E13) or just
after (E14) prepapilla placodes ap-
pear. This means that EGF prevents
formation of prepapilla placodes and
thus, papillae, from E13; and, pre-
vents differentiation of placodes to pa-
pillae from E14. The concentration-
dependent effects at E13 vs. E14
suggest that EGF is more potent in
promoting the inter-papilla epithe-
lium at E14, when tongue epithelium
is further committed along a dual dif-
ferentiation path to taste papilla or
nontaste epithelium.
We did not make a detailed study
beyond the stages of placode and pa-
pilla formation in culture (begun at
E13, E14). However we did observe
effects of exogenous EGF at 10 ng/ml
and higher concentrations in cultures
begun at E15 and E17, after papillae
have formed (not illustrated). The ef-
fects were apparently more pro-
nounced on the epithelial surface than
on papilla number per se, but would
be interesting for further experi-
ments.
EGF Endogenous and
Exogenous Effects on Papilla
Formation Are Mediated by
EGFR
To determine whether EGF effects on
papillae are mediated by means of
EGFR, we used a potent, specific
EGFR inhibitor, Compound 56
(Bridges et al., 1996), in tongue cul-
tures. First, we demonstrated EGFR
distribution with immunohistochem-
istry. In E142 day cultures, EGFR is
intensely localized in all layers of dor-
sal epithelium in the inter-papilla
space, but is very weak or absent
within the papilla epithelium (Fig.
4A), similar to the distribution in E16
embryonic tongue in vivo (Fig. 1).
When Compound 56 is added to
STAND, to block EGFR action, the
number of fungiform papillae that
form is increased by 38% at 1 nM
concentration or higher (ANOVA,
F(3,15)  7.4; P  0.01; Bonferroni
test, P  0.05; Fig. 4B graph). Fur-
thermore, fungiform papillae assume
fused or clustered distributions on the
anterior tongue with inhibition of en-
dogenous EGF action (compare insets
in Fig. 4B, scanning microscopy im-
ages, for 0 vs. 1 M inhibitor). These
fused and clustered papillae suggest
actions of EGF by means of EGFR in
the epithelium between papillae.
In cultures incubated with Com-
pound 56 alone followed by concomi-
tant use of EGF (Fig. 4C), the EGF-
mediated decrease in papilla number
is completely reversed by 1 M or
higher concentration of Compound 56
(ANOVA F(4,19)  34.6; P  0.01;
Bonferroni test, P  0.01; Fig. 4C
graph). Thus, the EGF effect is
blocked by EGFR inhibition. A very
high concentration of inhibitor (10
M) is not toxic but maintains papilla
numbers at levels of STAND culture
(Fig. 4C graph).
The data demonstrate that both en-
dogenous and exogenous EGF-in-
duced effects on fungiform papilla de-
Fig. 2. Scanning electron microscope images of embryonic day (E) 13 and E14 embryo tongues
before and after 2 days in culture. E13: At E13 the tongue presents a homogeneous surface
topography, composed of a posterior tuberculum impar (TI) and two anterior lingual swellings (L)
(E13,  0 day). There is no apparent differentiation of surface epithelium into prepapilla and
inter-papilla regions. After dissection from the mandible and organ culture for 2 days (2 days),
fungiform papillae form on the anterior tongue swellings and the posterior intermolar eminence (IE)
is papilla-free. An arrow at the posterior border of oral tongue points to the developing circumval-
late papilla. E14: Tongues at E14 have a spatulate shape with fused lingual swellings (E14, 0 day).
Fungiform papillae have not yet formed, but small protuberances, the prepapilla placodes, are
apparent in rows down either side of the median furrow (arrowheads). The large, papilla-free IE is
seen on posterior tongue. After 2 days in culture, fungiform papillae have formed on anterior tongue
(2 days). An arrow at the posterior tongue border points to the developing circumvallate papilla.
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Fig. 3. Epidermal growth factor (EGF) reduces fungiform papilla number in embryonic day (E) 13 and E14 tongue cultures. A: E13  2 day cultures:
Scanning electron micrographs (SEMs, left column) and whole tongue immunoreactions for Shh (Shh-ir, right column) demonstrate a concentration-
dependent decrease in papillae with 1 to 100 ng/ml EGF, compared with STAND tongue cultures (0 ng/ml EGF). At each EGF concentration, Shh-ir
is retained in remaining papillae. B: Histogram of fungiform papilla number (means  SE) demonstrates a significant effect (*) at 10 ng/ml EGF
(approximately 38% of papillae are lost) and a reduction of more than 77% with 100 ng/ml EGF, compared with 0 ng/ml. Also, there are significant
concentration effects between 1 vs 10, and 10 vs 100 ng/ml (#). Numbers within bars are numbers of cultures in each group. C: E14  2 day cultures:
SEMs (left) and Shh-ir (right) demonstrate a reduction in papillae when EGF is added to STAND cultures (0 ng/ml EGF). Shh is retained in all remaining
fungiform papillae (Shh-ir), at each EGF concentration. D: Papilla number (mean  SE) is decreased at 3, 10, 30, or 100 ng/ml compared with 0 ng/ml
EGF (*). The reduction is by approximately 47% with 10 ng/ml EGF and by more than 64% at 100 ng/ml (* indicates a significant reduction from 0
concentration; # indicates other significant, between-concentration effects). Numbers within bars are numbers of cultures in each group. Scale bars 
500 m, all micrographs in A and C.
velopment are mediated by means of
EGFR, which is located in the inter-
papilla epithelium. Endogenous EGF
apparently acts to sustain the inter-
papilla epithelium; exogenous EGF
decreases papillae and promotes the
inter-papilla epithelium.
Exogenous EGF Increases
Cell Proliferation in Lingual
Epithelium Between Papillae
Based on immunohistochemical local-
ization and demonstrated action of
EGFR, EGF must signal in the be-
tween-papilla epithelium of the
tongue. To further understand sites
where EGF could act during papilla
development, Ki67 was used to label
and compare proliferating cells in E14
and E16 tongues and in E142 day
cultures. In the E14 tongue, Ki67-pos-
itive cells are in the epithelium be-
tween papilla placodes (Fig. 5A, E14).
Within the placode epithelium (arrow-
head), however, proliferating cells are
absent or rare. At E16, also, the well
formed fungiform papillae have no or
few proliferating cells (Fig. 5A, E16,
arrows). Thus, within papillae, which
have reduced EGFR, there is little cell
proliferation. In contrast, the epithe-
lium between papillae, where EGFR is
intense, has numerous Ki67-positive
cells (Fig. 5A, E16). Ki67-labeled cells
are also present in the mesenchyme at
both E14 and E16, and are especially
numerous at E14.
In E142 day cultures, there is a
similar distribution of Ki67 immuno-
products. Inter-papilla cells are prolif-
erating but Ki67 is essentially absent
within the fungiform papilla epithe-
lium (Fig. 5A, E142, STAND, ar-
rows). However, with added EGF in
cultures, Ki67-cells are especially nu-
merous in the expanded inter-papilla
epithelium, compared with STAND
cultures (Fig. 5A, E142, EGF 100
ng/ml).
To quantify proliferating cells in the
inter-papilla epithelium, we used
Ki67 immunoreactions on sections of
STAND and EGF (10 ng/ml) tongue
cultures mounted on the same slides,
and counted Ki67 cells in epithelium
between fungiform papillae (Fig. 5B).
With exogenous EGF, there is an al-
most twofold increase in Ki67 cell
density in inter-papilla epithelium
compared with STAND cultures.
Fig. 4. Epidermal growth factor receptor (EGFR) mediates the EGF effect on fungiform papillae in
embryonic day (E) 14 tongue cultures. A: EGFR immunohistochemistry (EGFR-ir) in sagittal sections
of E14  2 day STAND tongue culture. A box on the section of an entire culture encloses region of
higher power image at right. EGFR is intensely localized in inter-papilla epithelium, but very weakly
in the apical papilla epithelium (arrowheads). Scale bars  250 m for section of entire culture; 50
m for high power image. B: Scanning electron micrographs (SEMs, top) and histogram (bottom)
of percentage of papilla number relative to STAND (0 concentration EGFR inhibitor) in tongues
cultured with the EGFR inhibitor, Compound 56. Inhibition of EGFR resulted in an increase of papilla
number at 1 nM and above, and fusion of papillae (arrows in SEMs; and compare merged papillae
in inset for 1 M inhibitor, to inset at 0 concentration). C: SEMs (top) and histogram (bottom) for
cultures with Compound 56 inhibitor plus EGF. Compound 56, at 1 M or higher, completely
reversed the EGF-induced decrease in papilla number. Cultures were incubated with Compound 56
alone for 1 hr, followed by culture with Compound 56 and exogenous EGF at 10 ng/ml. Scale bar:
 250 m for all SEMs. (*P  0.05 compared with control or 0 concentration inhibitor, blank bar;
#P  0.05 compared with EGF group without inhibitor.)
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Thus, there are more proliferating
epithelial cells between papillae in
cultures with exogenous EGF. We
know that EGFR also is localized to
epithelium between fungiform papil-
lae, confining EGF site of action to
inter-papilla tissue. Furthermore,
proliferating cells almost double in
density in epithelium between papil-
lae, when EGF is added to tongue cul-
tures. Together, results suggest that
EGF maintains inter-papilla epithe-
lial cells in a proliferative cycle and
thereby biases against differentiation
to fungiform papillae.
EGF Effect Can Over-ride
SHH Signal Disruption
To further explore the potency of EGF/
EGFR signaling in altering the inter-
papilla epithelium, we tested the abil-
ity of EGF to overcome a potent
stimulus to increase papilla number.
We had previously reported that,
when SHH signaling is disrupted with
the alkaloid cyclopamine (CYCL), fun-
giform papillae form in doubled num-
bers (Mistretta et al., 2003) and, fur-
thermore, develop on the usually
papilla-free intermolar eminence. We
repeated this effect and illustrate in
Figure 6 that there are 154 fungiform
papillae in STAND culture compared
with 418 with CYCL. Furthermore,
with CYCL, fungiform papillae have
formed on the intermolar eminence.
To determine whether exogenous EGF
can block the dramatic increase of pa-
pilla number induced by SHH disrup-
tion, we preincubated the E14 tongue
with EGF and cultured the tongue for
2 days with EGF plus CYCL (Fig. 6).
EGF at 10 ng/ml prevents the CYCL-
induced papilla formation on the in-
termolar eminence (Fig. 6, 10 ng/ml
EGFCYCL) but papillae number
233 and so have increased on anterior
tongue. However, with 100 ng/ml
EGF, the CYCL-induced changes in
papilla pattern and number are to-
tally prevented (Fig. 6, 100 ng/ml
EGFCYCL; papilla number  158).
Thus, EGF can prevent the increase in
fungiform papilla number induced by
interrupting SHH signaling, biasing
against differentiation and formation
of supernumerary papillae.
PI3K/Akt, MEK/ERK, p38
MAPK Signaling in Papilla
Response to EGF
For EGF to promote proliferation of
the inter-papilla epithelium, intracel-
lular pathways must be activated. Ty-
rosine kinase intracellular cascades
are known to be active in EGF/EGFR
signaling mechanisms and in promot-
ing proliferation and other cell pro-
cesses (Jorissen et al., 2003; Irmer et
al., 2007). To study PI3K and mitogen-
activated protein kinases (MAPK) in
fungiform papilla responses to EGF,
phosphorylated Akt, ERK1/2 and p38
MAPK first were immunolocalized
and analyzed with Western blot as-
says in E142 day tongue cultures.
Then specific inhibitors to PI3K/Akt,
MEK/ERK, or p38 MAPK (LY294002,
U0126, or SB203580, respectively)
were added to culture medium in a
1-hr incubation period, with subse-
quent concomitant EGF addition for
up to 2 days.
In STAND cultures, phosphorylated
Akt, -ERK1/2, and -p38 MAPK are
present in both papilla and inter-pa-
pilla epithelium (Fig. 7A, STAND).
The phosphoproteins are intense in
the apical papilla epithelium (dots),
and are observed also in underlying
mesenchyme. When EGF is added to
STAND, all three kinases are more
intense throughout the epithelium
(Fig. 7A, EGF), especially in the ex-
panded inter-papilla epithelium (re-
gions between arrows; see for exam-
Fig. 5. Exogenous epidermal growth factor (EGF) promotes cell proliferation in inter-papilla
epithelium. A: EGF and signaling in inter-papilla epithelium. Ki67-ir labels proliferating cells (black)
in sagittal sections of embryonic day (E) 14 and E16 tongue (E14, E16) and E14  2 day tongue
cultures (E142, STAND and EGF). E14 and E16 embryo tongues: Ki67-labeled cells are absent or
rare in the epithelium of prepapilla placodes (E14, arrowhead) of the E14 embryo tongue, and are
absent from fungiform papilla epithelium (E16, arrows) at E16. E14  2 day culture with STAND: As
at E16, Ki67-labeled cells are more numerous between, than within papillae in E14  2 day tongue
cultures. Arrows point to fungiform papillae and the open arrow points to a papilla sectioned
through the edge, not center. E14 2 day culture with EGF: With added EGF at 100 ng/ml, Ki67
immunoproducts are much more numerous and dense within the expanded, inter-papilla epithe-
lium. Arrows point to two papillae. Scale bar  50 m for all images. B: Ki67 immunoreactions of
E14  2 day cultures in STAND or EGF (10 ng/ml) and histogram for Ki67-positive cell density.
STAND and EGF sections were together on the same slides for immunoreactions. Dotted line marks
boundary between epithelium and mesenchyme. Ki67-positive cells (dark red) per area of epithe-
lium were counted and data normalized as fold change in the histogram (means  SE). With EGF,
density of Ki67 cells was almost doubled, compared with cultures in STAND. (**P  0.01,
compared with STAND.)
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ple, phosphorylated p38 MAPK in
STAND vs. EGF).
To compare phosphorylated kinases
in different conditions, we examined
epithelial sheets dissociated from
whole tongue cultures with Western
blots. In addition, inhibition of activa-
tion for each kinase was evaluated in
separate experiments with a specific
inhibitor. We used an antibody that
detects endogenous levels of phos-
phorylated ERK1/p44 MAPK and
ERK2/p42 MAPK. Therefore, double
bands are seen in ERK1/2 Westerns.
Exogenous EGF induces a substantial
increase in levels of phosphorylated
Akt and ERK1/2 in the epithelium of
tongue cultures without distinct alter-
ation of total protein level (Fig. 7B).
Note that this effect is apparent in
epithelium from cultures with EGF in
STAND and with EGF in dimethyl
sulfoxide (DMSO). Furthermore, spe-
cific inhibitors to PI3K/Akt and MEK/
ERK totally block this activation (Fig.
7B, Inhibitor). Whereas levels of phos-
phorylated Akt could seem relatively
small with EGF activation, it should
be noted that small differences in ac-
tivated Akt can have significant func-
tional consequences. (Rogulski et al.,
2005).
No change in phosphorylated p38
MAPK level was observed in Western
blots with addition of EGF in contrast
to data from immunohistochemistry
experiments (Fig. 7B). Furthermore,
phosphorylation of p38 MAPK was not
blocked by a specific inhibitor,
SB203580. In fact, though, these re-
sults are consistent with other reports
indicating that SB203580 blocks ac-
tivity of p38 MAPK and subsequent
activation of target proteins without
suppressing activation (phosphoryla-
tion) of p38 MAPK itself (Young et al.,
1997; Godl et al., 2003; Morel et al.,
2005).
With a direct functional assay of pa-
pilla counts, we found that the EGF-
dependent decrease in fungiform pa-
pilla numbers is fully reversed by
inhibiting PI3K activation with
LY294002, or of MEK/ERK with
U0126, in a concentration-dependent
manner (ANOVA F(3,15)  15.8; P 
0.01; F(3, 15)  22.2; P  0.01 respec-
tively; Fig. 8A,B). Inhibition of p38
MAPK with SB203580 blocks the
EGF-induced decrease in papillae
only at high concentration (30 M;
ANOVA F(3,23)  13.7; Bonferroni
test; P  0.01). SB202474, which is
structurally similar to SB203580 but
inactive in inhibiting p38 MAPK ac-
tivity, does not have an effect on the
EGF-induced papilla reduction. Addi-
tion of any inhibitor alone to tongue
cultures does not alter fungiform pa-
pilla numbers compared with controls.
In summary, results from immuno-
histochemistry, Western blot analyses,
and functional tests of papilla develop-
ment demonstrate that components of
PI3K/Akt, MEK/ERK, and p38 MAPK
cascades are present and activated in
embryonic tongue epithelium. Activa-
tion is increased by exogenous EGF in
culture, especially in the inter-papilla
epithelium. Effects on papilla number
in response to EGFR stimulation are
prevented by specific inhibitors, indicat-
ing that intracellular pathways include
PI3K/Akt, MEK/ERK, and p38 MAPK.
Synergistic Effects of MEK/
ERK With PI3K/Akt or p38
MAPK
In the absence of EGF, there was no
change in papilla number on inhibi-
tion of PI3K/Akt, MEK/ERK, or p38
MAPK (Fig. 8B). Furthermore, at low
concentrations of inhibitors, there was
no reversal of the EGF-dependent de-
crease in fungiform papilla numbers.
These signaling cascades would pre-
dictably act in concert in the embry-
onic tongue, and there are additive
effects among these cascades in other
systems (Larsen et al., 2003; She et
al., 2005), Therefore, we tested
whether simultaneously blocking two
or three pathways would alter papilla
number.
Without exogenous EGF, combina-
tions of USB, or ULYSB, at 3 M
(not effective for any one inhibitor
alone to alter the number of fungiform
papillae, or to alter the exogenous
EGF effect), lead to an increase of ap-
proximately 25% in number of fungi-
form papillae, apparently blocking the
role of endogenous EGF in maintain-
ing an inter-papilla epithelium (Fig.
8C, Graph at left; ANOVA F(10,50) 
5.2; P  0.01; Bonferroni test; P 
0.05).
With increased, 10 M inhibitor
concentrations, ULY in addition to
USB or ULYSB lead to an in-
creased number of fungiform papillae,
by approximately 35% (Fig. 8C Graph
in middle; ANOVA F(11,56)  32.5;
P  0.01; Bonferroni test; P  0.05).
Fig. 6. Exogenous epidermal growth factor (EGF) blocks Sonic hedgehog (SHH) signal disruption
effects that double numbers of fungiform papillae. Scanning electron micrographs (SEMs) of
embryonic day (E) 14  2 day tongue cultures show that exogenous EGF prevents the increased
and atypical fungiform papilla formation induced by SHH disruption with 5 M cyclopamine (CYCL).
Tongues were cultured with STAND; with added CYCL; with CYCL plus EGF after 1 hr preincu-
bation with 10 ng/ml EGF; or with CYCL plus EGF after 1 hr preincubation with 100 ng/ml EGF.
Papilla numbers are indicated in the top, right corner in each image. EGF at 10 ng/ml prevented the
CYCL-induced, atypical formation of fungiform papillae on the intermolar eminence (IE), while 100
ng/ml EGF totally blocked the CYCL-induced change in fungiform papilla development and
numbers (418 papillae with CYCL; 158 papillae with 100 ng/ml EGF  CYCL). An arrow points to
the border of oral and pharyngeal tongue in STAND culture. Scale bar  500 m, all micrographs.
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Combined use of LYSB, however,
does not affect papilla numbers, even
at 10 M concentration.
It is noteworthy that, during EGFR
activation with exogenous EGF in cul-
tures, even 3 M inhibitor concentra-
tions are effective in demonstrating
ULY, USB and ULYSB com-
bined effects to block an EGF-induced
decrease in papilla number (Fig. 8C,
Graph at right; ANOVA F(14,80) 
28.2; P  0.01; Bonferroni test; P 
0.05). Again, use of LYSB does not
block EGF effects (Fig. 8C, Graph at
right). The results suggest a synergis-
tic role of MEK/ERK with either PI3K/
Akt or p38 MAPK in regulating the
EGF-mediated effect on papilla devel-
opment.
DISCUSSION
The fungiform papilla is a taste organ
that develops early in the embryo to
provide a specialized tissue home for
eventual taste bud differentiation on
the anterior tongue; therefore, at
some point in papilla development,
taste cell progenitor epithelium re-
sides within the papillae (Mistretta
and Liu, 2006). Covering the remain-
ing anterior tongue dorsum is the de-
veloping inter-papilla epithelium that
will differentiate to form nongusta-
tory, filiform papillae. To regulate
taste papilla development and pat-
tern, then, factors effective in emer-
gence of the taste organ itself, and the
lingual tissue between organs, must
be active.
Here, we demonstrate that EGF sig-
naling through EGFR is a key regula-
tor of the inter-papilla epithelium and
number of fungiform papillae. EGF is
in early, embryonic tongue epithelium
and remains distributed throughout
lingual and differentiating papilla ep-
ithelium. In contrast, EGFR is pro-
gressively restricted to inter-papilla
epithelium and essentially is absent
from developing and advanced papil-
lae. This restricts principal EGF ac-
tion to the inter-papilla epithelium.
Exogenous EGF in E13 or E14 tongue
cultures regulates papilla pattern
by reducing numbers of papillae,
whereas inhibition of endogenous
EGFR increases fungiform papilla
numbers and fuses adjacent papillae,
effectively eliminating an inter-pa-
pilla space. In the embryo, epithelial
Fig. 7. Signaling by means of PI3K/Akt, MEK/ERK and p38 MAPK in the EGF effect on fungiform
papilla number and spacing. A: Phosphorylated (p-) Akt, ERK1/2, and p38 MAPK immunoreactions
in sagittal sections of E142 day cultures. Tongues were in standard medium (left column, STAND)
or with addition of 10 ng/ml EGF (right column, EGF). STAND and EGF culture sections were
together on the same slide for immunoreactions. For p-Akt, whole tongue sections at top illustrate
clarity of immunoreactions. For p-Akt images at higher power, a white line demarcates border of
epithelium from mesenchyme (STAND and EGF). p-Akt, p-ERK, and p-p38 MAPK each is present
in tongue epithelium (STAND), and is especially intense in the apical epithelium of papillae (dots).
Note that immunoproducts are relatively weak in STAND inter-papilla epithelium (between arrows)
compared with more intense immunoreactions with exogenous EGF (EGF) in inter-papilla epi-
thelium (between arrows). Scale bars  250 m in p-Akt images (entire sections), 25 m (higher
power of sections) applies to other section images. B: Western blots demonstrate the following:
presence of p-Akt, p-ERK1/2 (p- ERK1/p44 MAPK and ERK2/p42 MAPK), and p-p38 MAPK in
cultured tongue epithelium dissociated from underlying mesenchyme; an increased p-Akt and
ERK1/2 product in the presence of EGF; and, complete inhibition of activated kinase in the
presence of specific inhibitors (#  LY294002 for Akt, #  U0126 for ERK). However, there was not
an increase in p-p38 MAPK with EGF, and the specific inhibitor, SB203580 (#), did not block
activation of the kinase. Level of each of the total kinases (i.e., phosphorylated and non-phospho-
rylated) is not altered in experimental conditions. (# refers to a different, specific inhibitor that was
used for each kinase.)
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cell proliferation is substantially re-
duced in emerging papilla placodes
and developing papillae, compared
with the highly proliferative, inter-pa-
pilla tongue epithelium where EGFR
is localized. Indeed added EGF stimu-
lates further proliferation of inter-pa-
pilla epithelial cells in tongue cul-
tures. EGF can block the doubling of
differentiated fungiform papillae that
results from disruption of SHH signal-
ing, further indicating a bias to main-
tain inter-papilla epithelium. We pro-
pose that alteration of epithelial cell
differentiation programs is a primary
mechanism underlying EGF effects,
which holds inter-papilla cells in a
proliferative cycle and thereby inhib-
its cell differentiation programs for
fungiform papilla formation. The spe-
cific effects of EGF/EGFR-mediated
papilla patterning act through intra-
cellular cascades, including PI3K/Akt,
MEK/ERK, and p38 MAPK. Further-
more, interactive roles of MEK/ERK
with PI3K/Akt and with p38 MAPK
are apparent.
EGF Signaling Through
EGFR and Papilla Effects
EGF is abundant in saliva, approxi-
mately 1 g/ml, which continually
bathes the tongue and promotes
health of oral tissues (Noguchi et al.,
1991). Whereas EGF in saliva has im-
portant roles in maintaining fungi-
form papilla integrity in adult (Mor-
ris-Wiman et al., 2000), we found that
endogenous EGF is present through-
out the embryonic epithelium. In em-
bryonic rodent, the submandibular
salivary gland is functionally differen-
tiated before birth (Hoffman et al.,
2002), so exogenous EGF also is poten-
tially available to developing oral tis-
sues.
Although not quantified, reduced or
aberrant papillae were observed in
stunted tongues with thin epithelium
in EGFR null mutant, postnatal sur-
viving mice (Miettinen et al., 1995;
Threadgill et al., 1995). Building on
these prior studies, Sun and Oakley
(2002) made a detailed study of taste
bud loss in fungiform papillae in
EGFR null mutants and in contrast to
prior reports did not observe a reduc-
tion in papillae, but did report an un-
specified number of fungiform papil-
lae with keratinized spines. This is
similar to aberrant fungiform papillae
in mice with salivary gland removal
(Morris-Wiman et al., 2000). Different
results across studies are not unex-
pected because the EGFR loss-of-func-
tion phenotype is reportedly highly
variable and dependent on the genetic
background (Kasper et al., 2006). In
sum, postnatal null mutants show
that signaling through EGFR is im-
portant in maintenance of taste and
nontaste papilla and tongue epithe-
lium but provide no clear picture of
EGF signaling effects in papilla for-
mation and lingual epithelial differen-
tiation.
EGFR belongs to a family of ErbB
receptor tyrosine kinases (Harris et
al., 2003; Jorissen et al., 2003): ErbB1
(the EGFR itself, HER-1), ErbB2
(Neu, or HER-2), ErbB3 (HER-3), and
ErbB4 (HER-4). In rats, ErbB1–3
have been detected in adult taste bud
cells in all three types of taste papil-
lae, and also in E16–20 papillae
(McLaughlin, 2000). ErbB2 individu-
ally cannot bind any known ligand
and ErbB3 can only signal in a com-
plex (Harris et al., 2003; Jorissen et
al., 2003; Shilo, 2005). In the present
study, we focused on EGFR, which is
the receptor for EGF binding and has
a stage-specific localization in inter-
papilla epithelium.
We identified a progressive, embry-
onic restriction of EGFR to inter-pa-
pilla tongue epithelium where it is in-
tensely expressed, in contrast to
distribution of EGF throughout
tongue epithelium. We further demon-
strated that EGF action is through
EGFR. The specific distribution of
EGFR in inter-papilla epithelium in-
dicates that EGF is a spacing factor
for fungiform papillae, because EGF
acts to increase proliferation in epi-
thelium that is between the papillae.
In addition, developmental effects of
the EGFR inhibitor, Compound 56,
are to increase papilla number and
fusion, in support of the conclusion
that EGF/EGFR plays a physiological
role in papilla patterning. In the
present study we focused on EGFR,
which is the receptor for EGF binding
and has a specific localization in inter-
papilla epithelium. Although EGFR
generally undergoes homodimeriza-
tion (Shilo, 2005), we cannot exclude
that other ErbB receptors expressed
in tongue epithelium that do not act as
homeodimers, form heterodimers with
EGFR, for example, EGFR/ErbB2, as
in skin and hair follicle development
(Mak and Chan, 2003).
Epithelial Cell Phenotypes
of Fungiform Papillae and
EGF/EGFR Function
The early fungiform papilla forms as a
placode and develops through epithe-
lial–mesenchymal remodeling (Mis-
tretta, 1998). Signaling in the epithe-
lium reportedly determines position of
newly formed papillae (Kim et al.,
2003) and in this study our focus has
been on epithelial events in particu-
lar. At papilla initiation (E14–E15,
rat), epithelial cells clustered in the
placode apex already are different in
shape and organelle density from sur-
rounding cells (Farbman and Mbiene,
1991). Moreover, epithelial cells in
placodes and early papillae are mitoti-
cally quiescent (Farbman and Mbiene,
1991; Mbiene and Roberts, 2003; Zhou
et al., 2006). In contrast, we show that
the surrounding lingual epithelium is
in a proliferative state (Fig. 5). The data
suggest that placode and early papilla
epithelial cells are no longer in the cell
cycle, reflecting differentiation.
EGFR-activated signaling stimu-
lates cell cycle progression, regulates
cell shape and motility, and inhibits
apoptosis (Woodburn, 1999; Olayioye
et al., 2000; Yarden and Sliwkowski,
2001). The specific distribution of
EGFR in inter-papilla tongue epithe-
lium, where cells are proliferating,
and absence of EGFR in embryonic
fungiform papillae, where epithelial
cells are not proliferating, suggest
roles for EGFR in determining epithe-
lial cell fate and, thus, in spacing fun-
giform papillae. There is a dramatic
increase in cell proliferation in the in-
ter-papilla region with addition of
EGF in culture. Furthermore, EGF
can block the effect of SHH signal dis-
ruption, to double the number of fungi-
form papillae. Together, our data sup-
port the hypothesis that EGF/EGFR
activation leads to increased cell cycle
progression while inhibiting differenti-
ation to a papilla pathway; this would
prevent formation of fungiform papillae
and thus reduce papilla number.
From our prior studies, we know
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that the inter-papilla epithelium is
competent to form fungiform papillae
(Mistretta et al., 2003). Therefore, we
had proposed that regulatory factors
must act directly or by means of other
signaling factors to suppress fungi-
form papilla formation and enable pat-
terned spacing of papillae. Our current
data provide strong evidence for EGF/
EGFR signaling in suppressing papilla
formation in part by sustaining cell pro-
liferation between papillae.
Fig. 8.
2388 LIU ET AL.
EGF in Development of
Epithelial Specializations:
Feather, Hair, and Denticle
EGF and EGFR are in chick embryo
skin before feather placodes form, and
then are reduced in placodes but
maintained in the inter-bud epidermis
(Atit et al., 2003). In culture, EGF
stimulates epidermal proliferation
and expands inter-bud EGFR gene ex-
pression, with a concurrent loss of
feather bud gene expression. Con-
versely, EGFR inhibitors result in loss
of inter-bud fate and lead to feather
bud fusion. In hair follicles, EGFR is
absent from epidermal cells over der-
mal condensates that mark the first
stage of follicle development (Green
and Couchman, 1984). EGF inhibits
formation of hair buds in embryonic
mouse skin culture (Kashiwagi et al.,
1997). In transgenic mice that consti-
tutively express EGF in skin, hair fol-
licle development is retarded in post-
natal animals and the epidermis is
thickened (Mak and Chan, 2003).
Overall, reports suggest that EGFR
directs epidermal cells to an inter-
feather or inter-follicle fate, whereas
inhibition of EGFR leads to feather or
hair follicle differentiation. In Dro-
sophila epidermis, belts of hair-like
denticles alternate with smooth cuti-
cle. Reduced EGFR signaling in-
creases inter-denticle apoptosis and
leads to fusion of adjacent denticle
belts (Urban et al., 2004), indicating a
conserved effect of EGF in epidermal
organ formation.
Distributions and effects of EGF/
EGFR signaling in the tongue epithe-
lium during papilla development are
similar to those in skin and outer cu-
ticle, during feather, hair follicle, and
denticle formation. EGFR expression
is in inter-papilla epithelium, and ac-
tivation with EGF results in increased
cell proliferation between papillae;
this leads to expansion of inter-papilla
space and loss of papillae. EGFR inhi-
bition induces increased number and
fusion of papillae. Our data add the
taste papilla as an epithelial special-
ization that relies on EGF/EGFR sig-
naling for patterning, and demon-
strates common EGF/EGFR effects in
developing tongue epithelium, an oral
mucosa, compared with skin.
Intracellular Pathways and
Synergistic Roles in EGF/
EGFR Signaling
EGF/EGFR signaling results in simul-
taneous activation of several intracel-
lular pathways, which can be func-
tionally linked (Jorissen et al., 2003).
We studied PI3K/Akt, MEK/ERK, and
p38 MAPK in papilla development,
pathways widely associated with cell
survival, proliferation, differentiation,
migration, and death that are prefer-
entially activated in response to
growth factors or cell stress (Jorissen
et al., 2003; Downward, 2004; Roux
and Blenis, 2004).
Signaling in tongue cultures.
We detected phosphorylated Akt,
ERK1/2, and p38 MAPK in lingual ep-
ithelium of nontreated E142 day cul-
tures with immunohistochemistry
and Western blots, suggesting active
endogenous signaling in embryonic
tongue. With EGF in tongue culture
medium, immunoproducts of phos-
phorylated Akt, ERK1/2, or p38
MAPK were more intense in the epi-
thelium compared with controls, im-
plicating all three signaling cascades
in the EGF effect on fungiform papilla
development. Increased kinase inten-
sity was especially pronounced in in-
ter-papilla epithelium, consistent
with expression of EGFR in this loca-
tion.
In support of data from immunore-
actions, in Western blot assays exoge-
nous EGF effected a dramatic in-
crease in levels of phosphorylated Akt
and ERK1/2 in the epithelium of
E142 day cultures. Furthermore,
when a specific inhibitor for each ki-
nase was used (LY294002 or U0126),
Akt and ERK1/2 phosphorylation was
completely blocked without change in
total kinase level.
However, no significant change in
phosphorylated p38 MAPK was ob-
served in Western blots, in contrast to
increased lingual immunoproducts of
phosphorylated p38 MAPK. In addi-
tion, when SB203580 was used to
block signaling through p38 MAPK,
the phosphorylation of p38 MAPK was
not inhibited in Western blot analysis.
This is similar to reports demonstrat-
ing that SB203580 inhibits activity of
p38 MAPK by blocking activation of
downstream factors, but not the acti-
vation/phosphorylation of p38 MAPK
itself (Godl et al., 2003; Morel et al.,
2005). SB203580 inhibits p38 and 
splice variants of p38 MAPK (Kumar
Fig. 8. Concentration-dependent and synergistic effects of LY294002 (PI3K/Akt inhibitor), U0126 (MEK/ERK inhibitor), and SB203580 (p38 MAPK
inhibitor) on papilla development in cultures with and without epidermal growth factor (EGF). A: Inhibition of PI3K/Akt, MEK/ERK, or p38 MAPK blocked
the effect of exogenous EGF on fungiform papilla development. Scanning electron micrographs (SEMs) of E142 day cultures with STAND; EGF;
DMSO  EGF; or, EGF plus inhibitors (LY294002 for Akt, U0126 for ERK, SB203580 for p38 MAPK). Total number of papillae is shown in the bottom
left corner of each image. In tongue cultures with EGF or EGF with DMSO, the number of papillae was decreased compared with STAND cultures. For
inhibitor effects, tongues were incubated with LY294002, U0126, or SB203580 alone for 1 hr, followed by concurrent exposure to EGF for up to 2 days.
Inhibitors for each kinase prevented the EGF-induced decrease in papilla number in tongue cultures. Scale bar  500 m for all images. B: Histograms
of papilla number (mean  SE) with each inhibitor alone (blank bars) or plus EGF (10 ng/ml; filled bars). Any inhibitor alone, from 3 to 30 M, does not
affect papilla number, compared with the control condition without EGF and inhibitor. However, inhibition of PI3K/Akt activation with LY294002, of
MEK/ERK with U0126, or of p38 MAPK with SB203580 reverses the EGF-induced decrease in fungiform papilla numbers, in a concentration-
dependent manner. SB202474 is a structural control molecule for SB203580. (*P  0.05 compared with the group at the same concentration of
inhibitor but without EGF, or filled to matched blank bar; #P  0.05 compared with the EGF-alone group, or first filled bar.) C: Histograms of percentage
of papilla number (fungiform papilla number/mean number in vehicle control group  100%; mean  SE) at 3 M (left), or 10 M (middle) inhibitor
concentrations; or with EGF addition after preincubation with inhibitor for 1 hr (right). Without exogenous EGF, combinations of USB, or ULYSB,
at 3 M lead to an increase in number of papillae (*). Without exogenous EGF, ULY, USB, or ULYSB, at 10 M, lead to an increased number
of papillae, by approximately 35% (*). The combined use of LYSB, however, does not affect papilla numbers. In the presence of exogenous EGF,
3 M inhibitor concentrations are effective in blocking an EGF-induced decrease in papillae with combined use of ULY, USB or ULYSB. Again,
use of LYSB does not block EGF effects. (*P  0.05 compared with the vehicle [DMSO] control group, white bars; #P  0.05 compared with the EGF
alone group.)
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et al., 2003); p38 reportedly is the
most physiologically important vari-
ant, but p38 has suggested roles in
protecting against apoptosis (Yang et
al., 2004). Clearly, p38 MAPK path-
ways are complex and further experi-
ments are required to understand the
SB203580 inhibition of p38 MAPK ac-
tivity in our tongue culture system.
Functional effects and
synergistic actions on papilla
number.
With inhibitors to PI3K, MEK/ERK,
or p38 MAPK signaling, we found that
any inhibitor alone did not alter pa-
pilla number and pattern in culture
without exogenous EGF. However,
with combined inhibitors, there was a
dramatic increase in papilla number
indicating synergistic signaling ac-
tions in endogenous papilla pattern-
ing. The MEK/ERK cascade may be a
primary component in these synergies
because alteration of papilla number
occurred only when MEK/ERK inhibi-
tion was in conjunction with PI3K/Akt
or p38 MAPK inhibition; combined
use of inhibitors of the latter two ki-
nases did not have an additive effect.
In a concentration-dependent man-
ner, any one of the inhibitors,
LY294002 for PI3K/Akt, U0126 for
MEK/ERK, or SB203580 for p38
MAPK, blocked the effect of exogenous
EGF in reducing fungiform papilla
number. Moreover, at 3 M concen-
tration, which is not effective alone,
combined U0126 with LY294002 or
SB203580 blocked the EGF-induced
decrease in papilla number. Use of
LY294002 with SB203580 did not
block EGF effects. This further dem-
onstrates a synergistic role of MEK/
ERK with PI3K/Akt and p38 MAPK in
regulating the EGF-mediated effect
on papilla pattern. Additive effects
among these cascades are noted in
other systems (Larsen et al., 2003;
She et al., 2005). Furthermore, sensi-
tivity to tryosine kinase inhibition is
dependent on cell context and can al-
ter with and without growth factor
stimulation (Irmer et al., 2007).
Therefore, differences in concentra-
tion and synergistic parameters when
inhibitors are used without or with
EGF stimulation are not unexpected.
While other secreted proteins might
affect papilla development through
the PI3K/Akt and MEK/ERK and p38
MAPK signaling cascades that we
have localized in developing tongue
epithelium and papillae, these other
potential effects have not yet been
studied. We have clearly shown that
exogenous EGF will not only lead to
phosphorylation of these kinases, but
also that when these pathways are






Cell cycle progression assessed by pro-
liferation in embryonic tongue and
tongue cultures is pronounced be-
tween papilla placodes or papillae, and
is virtually absent within placodes or
papillae. We propose that primary ef-
fects of EGF/EGFR activation on pa-
pilla spacing and pattern are by
means of signaling in the inter-papilla
epithelium, through PI3K/Akt, MEK/
ERK, and p38 MAPK cascades in-
volved in cell survival, proliferation,
differentiation, migration, and/or apo-
ptosis (Fig. 9A). If PI3K/Akt, MEK/
ERK, or p38 MAPK signaling is inhib-
ited, more fungiform papillae form in
EGF stimulated cultures. Our data
are congruent with the idea that
EGFR-mediated EGF regulation of
papilla number and pattern acts
through signaling in the epithelium
between papillae. An inter-papilla ep-
ithelial fate is promoted, rather than a
papilla differentiation pathway.
In addition to EGF signaling in the
inter-papilla epithelium, we previously
have demonstrated that BMP2, 4, or 7
reduces formation of fungiform papillae
(Zhou et al., 2006). Comparison of EGF
and BMP effects in reducing papilla
number is informative. In cultures with
implanted beads, BMPs lead to thin-
ning and much reduced proliferation in
the tongue epithelium (Zhou et al.,
2006). The BMP antagonist noggin, on
the other hand, elicits formation of mul-
tiple papillae and a thicker, highly pro-
liferative epithelium. BMP signaling ef-
fects, then, are very different from those
of EGF, although both lead to reduced
papillae. Whereas EGF promotes cell
proliferation in inter-papilla epithelium
and biases away from fungiform papilla
differentiation, BMP reduces cell sur-
vival and proliferation and inhibits pa-
pilla formation (Fig. 9B). Clearly, these
are factors that must be balanced in
developing tongue epithelium for pat-
terned formation of taste organs.
Fig. 9. Epidermal growth factor (EGF) signaling effects in inter-papilla epithelium, and model to
compare EGF and bone morphogenetic protein (BMP) in fungiform papilla reduction. A: EGF
signaling is progressively constrained to inter-papilla epithelium by restricted location of EGF
receptor (EGFR) to inter-papilla tissue. Signaling through PI3K/Akt, MEK/ERK, and p38 MAPK
cascades can interact and potentially regulate cells in the inter-papilla epithelium (for survival,
proliferation, differentiation, or apoptosis), effectively biasing away from a fungiform papilla
fate. B: The model indicates that both exogenous EGF (current study) and BMPs (BMP2, 4, or 7;
Zhou et al., 2006b) reduce numbers of fungiform papillae in embryonic tongue. EGF signaling
expands the inter-papilla space through a proliferative effect on between-papilla epithelium that
biases cells away from papilla differentiation. In contrast, excess BMP effects a thinner, nonpro-
liferative inter-papilla epithelium. Thus, whereas both EGF and BMP prevent papilla formation,
different mechanisms are used. [Color figure can be viewed in the online issue, which is available
at www.interscience.wiley.com.]
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Furthermore, counter to and/or in-
teracting with EGF signaling can be
stage- and concentration-specific ef-
fects of SHH (Liu et al., 2004), NOG-
GIN (Zhou et al., 2006), or WNT mol-
ecules (Iwatsuki et al., 2007) in
papilla formation. We have shown
that EGF can block SHH signaling ef-
fects on papilla formation. In extend-
ing our results, it will be important to
determine whether, when, and how
EGF, BMP, NOGGIN, SHH, and
WNT signaling interact in papilla and
inter-papilla epithelial formation, and
how these interactions might be dis-
tinctive in accessing various intracel-





rats were from Charles River breed-
ers. Animal maintenance and use
complied with institutional animal
care protocols and were according to
National Institutes of Health guide-
lines. Morning of the day of vaginal
plug detection was designated embry-
onic day 0 (E0). All dissections of E13–
E18 embryos were between 9:00 AM
and 12:00 PM for consistency across
litters (Mbiene et al., 1997). Pregnant
dams were anesthetized with sodium
pentobarbital (intraperitoneal, 60
mg/kg body weight), also anesthetiz-
ing the embryos. Embryos were re-
moved from the anesthetized dam and
transferred to Earle’s balanced salt
solution with gentamicin sulfate, buff-
ered with 20 mM HEPES (pH 7.4;
Mistretta et al., 2003). Embryo heads
were dissected and moved to fresh so-
lution for cultures or rapidly frozen in
O.C.T. compound (Miles Scientific,
Elkhart, IN) for immunohistochemis-
try.
Tongue Cultures
E13 or E14 tongues were cultured for
2 days (Mbiene et al., 1997; Mistretta
et al., 2003). In brief, whole tongues
were dissected from the mandible and
placed on sterile Millipore HA filters
on stainless steel grids in culture
dishes. Cultures were fed with a 1:1
mixture of Dulbecco’s modified Eagle’s
medium and Ham’s nutrient F12
(DMEM/F12, GIBCO, Gaithersburg,
MD), containing 1% fetal bovine serum,
50 g/ml gentamicin sulfate, and 2%
B27 culture supplement (GIBCO; con-
trol or standard medium, STAND). The
level of medium was adjusted so that
cultures were at the gas/liquid inter-
face, in a humidified incubator at 37°C.
Cultures were made from E13 when
the tongue epithelium has a homoge-
nous topography and from E14 when
prepapilla placodes have just begun to
emerge on the tongue (Fig. 2, E13 and
E14, 0 day). After 2 days in culture,
fungiform papillae form on anterior
tongue of E13 or E14 cultures (Fig. 2,
E13 and E14, 2 days).
Reagents
To study roles of EGF in papilla devel-
opment, human recombinant EGF (1–
100 ng/ml; 236-EG, R&D Systems,
Minneapolis, MN) was added to
STAND. Effects of EGFR inhibition
were investigated with a specific and
potent inhibitor of EGFR, Compound
56 (4-[(3-Bromophenyl) amino]-6,7-di-
ethoxyquinazoline, Calbiochem, #234505,
San Diego, CA), added to STAND, or
co-administered with EGF (10 ng/ml)
after 1 hr incubation with Compound
56 alone (1 nM-10 M).
To determine intracellular path-
ways that mediate EGF effects, E14
cultures were incubated with specific
inhibitors alone for 1 hr followed by
exposure to a mixture of EGF and in-
hibitor for 2 days. LY294002 (A.G. Sci-
entific, San Diego, CA), U0126
(#662005), and SB203580 (#559389)
(Calbiochem, San Diego, CA) were
used to block PI3K, MEK1/2, and p38
MAPK, respectively. SB202474 (Cal-
biochem, #559387), a structurally sim-
ilar but inactive p38 MAPK antago-
nist, was used as a control for
SB203580. A concentration range be-
tween 3 to 30 M was used for inhib-
itors. Cultures in STAND, or with ad-
dition of the solvent DMSO for
inhibitors of EGFR and intracellular





SEM was used to evaluate surface to-
pography of tongues or tongue cul-
tures and acquire counts of fungiform
papillae in various culture conditions.
Tongues or tongue cultures were fixed
in 2.5% glutaraldehyde and 2% para-
formaldehyde (PFA) in 0.1 M cacody-
late buffer (pH 7.3) at 4°C, post-fixed
in a sequence of aqueous 1% OsO4, 1%
tannic acid, 1% OSO4, for 1 hr each on
ice, and processed as described
(Mbiene et al., 1997). Tissues were
mounted, sputter coated with gold/
palladium, and analyzed with SEM.
Digital images were acquired and as-
sembled using Photoshop (Adobe Sys-
tems, Mountain View, CA).
SEM images of E13 cultures at
100 and E14 at 75 original magni-
fication were used to count fungiform
papillae, with 5 to 13 tongues in each
experimental condition. Each papilla,
defined as a round or oval protuber-
ance that has a distinctive surface ep-
ithelium from surround (Fig. 2), is
marked and counted on a plastic over-
lay positioned over photographs of cul-
tures.
Papilla numbers are presented as
mean  standard error (SE). ANOVA
was used for papilla quantification,
followed by the Bonferroni post hoc
test, at a significance level of P  0.05.
Immunohistochemistry
Antibodies.
Primary antibodies were as follows:
EGF (#06-102, 1:400) and EGFR (#06-
129, 1:50–1:100; Upstate Biotechnol-
ogy, Lake Placid NY); EGFR (#SC-03,
1:200, Santa Cruz Biotechnology,
Santa Cruz CA); Shh (#AF464, 1:100,
R&D Systems, Minneapolis MN);
Ki67 (#NCL-Ki67p, 1:1000, Novocas-
tro Laboratories Ltd., UK; #M7248,
1:400, DakoCytomation, DK); p-Akt
(#9277, 1:300), p-p44/p42 MAPK or
ERK1/2 (#9101,1:250), and p-p38
MAPK (#9211, 1:100; Cell Signaling,
Beverly, MA). Slides treated with no
primary antibody or with the same
concentration of normal IgG were
used as controls. Specificity for EGFR
immunostaining was confirmed with
absorption tests (primary antibody
was incubated for 24 hr with 10	6 M
of the immunogen EGFR, before add-
ing to tissue sections).
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Whole tongue
immunohistochemistry.
To localize EGFR in embryo tongues
or Shh in tongue cultures, tongues
were fixed in 4% PFA in 0.1 M phos-
phate buffered saline (PBS), pH 7.4, at
4°C for 2 hr, and processed as de-
scribed (Liu et al., 2004).
Tissue section
immunohistochemistry.
To immunolocalize EGF, EGFR, and
phosphorylated -Akt, -ERK1/2, or -p38
MAPK, dissected embryo heads or
tongue cultures were frozen in O.C.T.
Serial sagittal sections were cut at 12
m, thaw-mounted onto gelatin
coated slides and fixed at 4°C for 1.5
hr in 4% PFA in 0.1 M PBS, pH 7.4.
After fixation, sections were reacted
as described (Mistretta et al., 2003;
Liu et al., 2004).
Ki67-Postive Cell
Quantification
Ki67 antigen is normally expressed in
nuclei of cells in all phases of the cell
cycle, and not in G0. We used Ki67
antibody to label proliferating cells.
To quantify Ki67 cells in STAND
and EGF cultures, serial sagittal sec-
tions were cut and sections from
STAND and EGF cultures mounted
on the same slides for immunoreac-
tions. A set of five to six nonconsecu-
tive sections (midway between the lat-
eral border and median furrow of the
tongue culture) was captured with
light microscopy and subsequently
viewed on screen, from STAND or
EGF cultures. For each captured sec-
tion, the basement membrane region
was outlined and a 150 m length of
tongue epithelium that did not include
fungiform papillae was marked. Each
Ki67 cell in the marked length of
epithelium that had a clearly labeled
nucleus was designated with a dot and
the section was photographed and
printed. Then, Ki67 cells (dots) were
counted in each photographed section.
For intensely labeled sections, often
seen with exogenous EGF, we cross-
checked slides under the light micro-
scope with on-screen images to be cer-
tain that Ki67 cells were accurately
marked with a dot. Inserting dots on-
screen allowed repeated viewing of
magnified images to optimize accurate
identification of Ki67 cells. To derive
a measure of Ki67 cells per area of
epithelium, total cell counts were di-
vided by area measurement (150 m
length of tongue epithelium  mea-
sured depth of epithelium from base-
ment membrane to surface, in m).
Data were normalized to cell counts in
STAND, to express a fold change in
cell density with exogenous EGF.
Western Blots
Total and phosphorylated Akt,
ERK1/2, and p38 MAPK were de-
tected with Western blot assays.
E142 day cultures were divided into
four groups (12 cultures/group) for
each protein kinase: standard me-
dium, STAND; EGF (10 ng/ml);
EGFDMSO; and, EGFkinase in-
hibitor (20 M LY294002, 10 M
U0126, or 30 M SB203580). After 2
days in culture, tongues were incu-
bated with dispase II (2.4 unit/ml,
Gibco, Germany) added to the original
culture medium for 30 min at 37°C.
The epithelial sheet was peeled from
mesenchyme and transferred to 0.2%
Nonidet-P40 lysis buffer containing
protease and phosphatase inhibitors
on ice for 10 min. The epithelial lysate
was centrifuged and the supernatant
collected. Protein content in the su-
pernatant was determined with the
Bio-Rad protein assay (Hercules, CA).
Equal amounts of protein were run
with sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis and
transferred to nitrocellulose mem-
brane. Procedures for blocking and
antibody probing were as described
(Mitra et al., 2003). Visualization of
immunoreactive proteins was accom-
plished by the chemiluminescence
system (Pierce, Rockford, IL) and ex-
posure to film.
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